Article Versions Notes

Moskal M, Krawiec P, Zaręba W, Świerczek I, Ratusznik J, Raputa W, Zieliński M, Batko K, Huk M, Batko B. Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients. International Journal of Environmental Research and Public Health. 2022; 19(23):15861. https://doi.org/10.3390/ijerph192315861

Moskal, Mateusz, Piotr Krawiec, Wojciech Zaręba, Izabella Świerczek, Jakub Ratusznik, Wiktor Raputa, Maciej Zieliński, Krzysztof Batko, Mikita Huk, and Bogdan Batko. 2022. "Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients" International Journal of Environmental Research and Public Health 19, no. 23: 15861. https://doi.org/10.3390/ijerph192315861

Moskal, M., Krawiec, P., Zaręba, W., Świerczek, I., Ratusznik, J., Raputa, W., Zieliński, M., Batko, K., Huk, M., & Batko, B. (2022). Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients. International Journal of Environmental Research and Public Health, 19(23), 15861. https://doi.org/10.3390/ijerph192315861